Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Liminatus Pharma Inc. (LIMN) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
-- |
|
$-1.41M |
|
-- |
|
-- |
|
$1.38M |
|
$-1.38M |
|
$-0.03M |
|
$-1.41M |
|
$-1.41M |
|
$-1.41M |
|
$-1.41M |
|
$-1.41M |
|
$-1.41M |
|
$-1.38M |
|
$-1.38M |
|
0.97M |
|
0.97M |
|
$-1.50 |
|
$-1.50 |
|
| Balance Sheet Financials | |
$3.39M |
|
$0.01M |
|
$0.01M |
|
$3.40M |
|
$3.04M |
|
-- |
|
$0.06M |
|
$3.10M |
|
$0.30M |
|
$0.30M |
|
$0.30M |
|
1.12M |
|
| Cash Flow Statement Financials | |
$-2.99M |
|
-- |
|
$5.66M |
|
$0.34M |
|
$3.02M |
|
$2.68M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.12 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
4.80 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.99M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-468.14% |
|
-468.13% |
|
-41.34% |
|
-468.13% |
|
$0.27 |
|
$-3.08 |
|
$-3.08 |
|